Tag: GCP compliance

Designing Consent and Assent Materials for Pediatric and Youth Populations

November 14, 2025November 14, 2025 digi

Designing Consent and Assent Materials for Pediatric and Youth Populations Designing Consent and Assent Materials for Pediatric and Youth Populations Designing consent and assent materials for pediatric and youth populations is a critical aspect of ensuring ethical compliance in clinical trials, particularly given the unique vulnerabilities present in these groups. This tutorial provides a step-by-step…

Vulnerable Populations (Pediatrics, Cognitively Impaired, Prisoners)

Source Documentation for Informed Consent: What Regulators Expect to See

November 14, 2025November 14, 2025 digi

Source Documentation for Informed Consent: What Regulators Expect to See The informed consent process is a crucial aspect of conducting clinical trials, particularly for conditions such as non-small cell lung cancer. For professionals engaged in clinical operations, regulatory affairs, and medical affairs, understanding the expectations set out by regulatory bodies like the FDA, EMA, and…

Informed Consent Process & Documentation

Designing Readable and Compliant Informed Consent Forms for Global Trials

November 14, 2025November 14, 2025 digi

Designing Readable and Compliant Informed Consent Forms for Global Trials Designing Readable and Compliant Informed Consent Forms for Global Trials The informed consent process is a cornerstone of ethical clinical research, particularly in msa clinical trials. As clinical trials expand globally, the challenge of creating accessible and compliant informed consent forms (ICFs) becomes increasingly paramount….

Informed Consent Process & Documentation

Defining and Monitoring Fair Participant Selection in Clinical Protocols

November 14, 2025November 14, 2025 digi

Defining and Monitoring Fair Participant Selection in Clinical Protocols Defining and Monitoring Fair Participant Selection in Clinical Protocols In the domain of clinical research, participant selection is not merely a logistical concern; it is a fundamental ethical obligation. Fair participant selection ensures that the individuals who comprise the study population are representative, allowing the findings…

Equity in Recruitment & Fair Participant Selection

Equity in Participant Selection: Designing Inclusive Recruitment Strategies

November 14, 2025November 14, 2025 digi

Equity in Participant Selection: Designing Inclusive Recruitment Strategies Equity in Participant Selection: Designing Inclusive Recruitment Strategies Understanding the Importance of Equity in Clinical Trial Recruitment Clinical trials are essential for advancing medical science and improving patient care. However, the success and generalizability of these trials largely depend on the diversity of their participants. Equity in…

Equity in Recruitment & Fair Participant Selection

Data Collection on Race, Ethnicity and Social Determinants: Ethics and Practice

November 14, 2025November 14, 2025 digi

Data Collection on Race, Ethnicity and Social Determinants: Ethics and Practice Data Collection on Race, Ethnicity and Social Determinants: Ethics and Practice Data collection concerning race, ethnicity, and social determinants of health (SDOH) within clinical trials is critical for ensuring that research outcomes are applicable to diverse populations. This tutorial guide aims to provide a…

Equity in Recruitment & Fair Participant Selection

Embedding Equity Considerations Into Eligibility Criteria and Exclusion Rules

November 14, 2025November 14, 2025 digi

Embedding Equity Considerations Into Eligibility Criteria and Exclusion Rules In the context of clinical research, ensuring equitable access to trials is a crucial element that can significantly influence the validity and applicability of study results. Participation in clinical trials often reveals significant disparities, influenced by a myriad of factors including socioeconomic status, geographic location, and…

Equity in Recruitment & Fair Participant Selection

Regulatory Expectations for Diversity Plans in Global Trials

November 14, 2025November 14, 2025 digi

Regulatory Expectations for Diversity Plans in Global Trials Regulatory Expectations for Diversity Plans in Global Trials In the ever-evolving landscape of clinical research, the integration of diversity plans within global trials has become a focal point of regulatory guidance and ethical considerations. As clinical operations, regulatory affairs, and medical affairs professionals engage in international projects,…

Equity in Recruitment & Fair Participant Selection

Avoiding Over-Burdening Specific Populations With Research Participation

November 14, 2025November 14, 2025 digi

Avoiding Over-Burdening Specific Populations With Research Participation Avoiding Over-Burdening Specific Populations With Research Participation In the realm of clinical research, equity in participant recruitment and selection is critically important for ensuring that research findings are applicable across diverse populations. A common challenge faced by clinical operations, regulatory affairs, and medical affairs professionals is the potential…

Equity in Recruitment & Fair Participant Selection

Community Partnerships to Improve Representation in Clinical Trials

November 14, 2025November 14, 2025 digi

Community Partnerships to Improve Representation in Clinical Trials Community Partnerships to Improve Representation in Clinical Trials The landscape of clinical trials is shaped by the imperative to ensure equitable representation of diverse populations. This necessity is not merely an ethical obligation; it is instrumental to the scientific validity and generalizability of research outcomes. Poor representation…

Equity in Recruitment & Fair Participant Selection